Facebook
Twitter
LinkedIn
Forward
The podcast episodes in Mayo Clinic Talks: Prostate Cancer and Men's Health Edition cover commonly seen health problems related to prostate cancer and men’s health in a primary care practice. Episodes specifically address the presentation, diagnosis and management of common prostate problems, such as benign prostatic hyperplasia (BPH), prostate cancer screening, prostate cancer treatment, prostate cancer and sexual health, updates in advanced prostate cancer, and primary care management of the post-prostate cancer patient.
Listening is free, no CME Credit available.
Mayo Clinic Talks is a podcast series targeted to the primary care clinician community. To listen to additional episodes with CME credit available, visit Mayo Clinic Talks Season 3
These talks on Men's Health are brought to you by Astellas Oncology. | |||||
| Episode 1: Benign Prostatic Hyperplasia (BPH) Benign prostatic hyperplasia or BPH is quite common in middle-age and older men. It’s estimated that up to 70% of men over age 60 have symptoms from BPH. While BPH is not a life-threatening condition, it does produce symptoms which can negatively affect the lifestyle of our patients. Since most of the patients with BPH are managed by primary care providers, we should be comfortable with the variety of treatment options available. When should treatment be initiated? What’s available pharmacologically? And when should a urologist be consulted to consider a surgical option? In this podcast, we’ll discuss these questions and more with Mitchell R. Humphreys, M.D., from the Department of Urology at the Mayo Clinic. Listen to this episode on your favorite podcast app below.
| ||||
| Episode 2: Screening for Prostate Cancer Prostate cancer is one of the most common malignancies in men, second only to skin cancer. It’s estimated that 1 in 8 men will develop prostate cancer during their lifetime. The predominant screening test for prostate cancer has been the prostate specific antigen or PSA. However, there has been some controversy surrounding the use of PSA. It’s an easily administered test, it’s relatively inexpensive and it’s capable of identifying men with possible prostate cancer. So, what’s the controversy? Is the PSA an effective screening test? Who should be tested and how have urologists modified their practice to manage patients with an elevated PSA? We’ll discuss these questions in today’s podcast on “Screening for Prostate Cancer” with our guest, Daniel M. Frendl, M.D., Ph.D., a urologist at the Mayo Clinic. Listen to this episode on your favorite podcast app below.
| ||||
| Episode 3: Treatment of Prostate Cancer Prostate cancer is the most common solid organ malignancy in males, and it’s estimated that 1 in 8 men will develop prostate cancer during their lifetime. When diagnosed early, it has an excellent survival rate with a variety of very effective treatment options. What are the advantages and disadvantages of each? Why would one option be chosen over another and how do the adverse effects of the various treatments differ? In this podcast, I’ll be discussing these questions with our guest, R. Jeffrey Karnes, M.D., a urologist at the Mayo Clinic. Listen to this episode on your favorite podcast app below.
| ||||
| Episode 4: Prostate Cancer and Sexual Health Issues related to the prostate can play a significant role in a man’s sexual function. We commonly use medications for benign prostate problems such as BPH which can produce adverse effects. It’s also very common for the treatment of prostate cancer, whether we use radiation therapy, surgical prostatectomy, or hormonal therapy to cause sexual dysfunction. In this podcast, we’ll review the important role the prostate plays in sexual function as we discuss the “Prostate and Sexual Health” with our guest, Nahid Punjani, M.D., M.P.H., a urologist at the Mayo Clinic. Listen to this episode on your favorite podcast app below.
| ||||
| Episode 5: Updates in Advanced Prostate Cancer Prostate cancer is the second most common malignancy in men, second only to skin cancer and due to increased efforts in screening, most prostate cancers are found very early and these men have an excellent survival rate. Unfortunately, a percentage of men develop an advanced prostate cancer and the disease becomes much more aggressive with significantly lower survival rates. Who’s at risk for advanced prostate cancer? How does the survival rate change with metastatic disease? Finally, what are the various treatment options and how effective are they? In this podcast, we’ll discuss these questions with our guest, Alan H. Bryce, M.D. from the Division of Hematology and Oncology at the Mayo Clinic.
| ||||
| Episode 6: Primary Care Management of the Post-Prostate Cancer Patient Except for skin cancer, prostate cancer is the most common malignancy in males. 1 in 8 men will be diagnosed with prostate cancer during his lifetime, most over the age of 65. If diagnosed early, treatment is quite effective and results in a very favorable survival rate. Several very effective treatment options are now available for patients. In this podcast, we’ll discuss the various treatments and what patients can expect following each option. We’ll review how a post-prostate cancer patient should be followed by their primary care provider and when there might be reason for concern of a recurrence. The guest for this podcast is Scott M. Cheney, M.D. a urologist from the Mayo Clinic in Phoenix, Arizona.
| ||||
